Research view
Switch to patient viewGastric and oesophageal cancer: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- HER2 84
- PD-1 108
- PD-L1 49
- CLDN18 35
- TP53 1
- PI3K 1
- AKT 1
- STAT3 1
- mTOR 0
- CTNNB1 0
- VEGF 7
- YAP 0
- MAPK 0
- EGFR 10
- ERK 0
- FGFR 1
- JAK 0
- HIF-1 0
- MYC 0
- PTEN 3
- CTLA-4 8
- NRF2 0
- MET 5
- STING 0
- CXCR4 0
- B7-H3 6
- JNK 0
- AMPK 0
- GPX4 0
- TROP2 6
- IL-6 0
- METTL3 0
- COX-2 0
- KRAS 2
- ARID1A 1
- BRCA1 2
- FAK 0
- LAG-3 0
- MDM2 0
- MMP-9 0
- PARP 0
- PPAR 0
- TIGIT 1
- BRCA2 1
- HSP90 0
- BCL-2 0
- FTO 0
- SHP2 0
- BRAF 0
- CD47 1
- CDK4/6 0
- HDAC 0
- HER3 3
- HMGB1 1
- MEK 0
- PDGFR 2
- TIM-3 0
- TNF 0
- ATM 0
- AXL 2
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
NIH NCI · R44
NIH NCI · R01
NIH NCI · R01
Mechanisms Underlying Emergence and Progression of Gastric Intestinal Metaplasia
NIH NCI · R01
Advancing the Use of the Kettles Esophageal and Cardia Adenocarcinoma Prediction Tool
NIH NCI · U01
Comparative Modeling of Gastric Cancer Prevention, Screening, and Surveillance in the US
European Commission (Horizon Europe) · HORIZON-RIA
IMproving the outcome of Peritoneal and Pleural metastases using Aerosolized ChemoTherapy (IMPACT)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-ERC
European Commission (Horizon Europe) · HORIZON-EIC
Hybrid endoscope for esophageal in vivo histology and histochemistry (ESOHISTO)
European Commission (Horizon Europe) · HORIZON-ERC
In vivo Immunofluorescence-Optical Coherence Tomography (Immuno-OCT)
The disease is named only in the funder's project summary, not in the title.
10 of 265 running projects, newest first. Listed amounts together: US$148.6m + €38.7m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 71
- Organoids 34
- Mendelian Randomization Analysis 42
- CRISPR-Cas Systems 9
- Gene Expression Profiling 198
- Sequence Analysis, RNA 9
- Whole Genome Sequencing 8
- Exome Sequencing 14
- Proteomics 55
- Metabolomics 42
- Mass Spectrometry 5
- Flow Cytometry 33
- Immunohistochemistry 151
- Liquid Biopsy 18
- Circulating Tumor DNA 25
- Xenograft Model Antitumor Assays 289
- Positron-Emission Tomography 22
- Magnetic Resonance Imaging 24
- Machine Learning 134
- Deep Learning 65
- Cohort Studies 175
- Genome-Wide Association Study 48
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.